Comparing Advanced Technologies to Standard Testing for the Diagnosis of Airway Disease in Hospital and Community Settings

NCT07798596 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-09-01

No results posted yet for this study

Summary

Airway disease, such as chronic obstructive pulmonary disease (COPD), is usually diagnosed through breathing tests like spirometry. However, it requires people to blow forcefully into a machine several times which can be uncomfortable and difficult for some patients.

This study is looking at whether newer technologies and other breathing tests can help diagnose COPD as accurately as standard testing. We will compare these tests in both hospital and community settings. We are interested in understanding how practical and cost-effective these tests are, including how easy they are to use and how comfortable they are for patients to perform.

Conditions

  • COPD (Chronic Obstructive Pulmonary Disease)
  • Airway Disease

Interventions

DIAGNOSTIC_TEST

Capnography

Capnography used in combination with machine learning-derived algorithms, with or without reversibility testing (if indicated on spirometry)

DIAGNOSTIC_TEST

Oscillometry

Oscillometry (where applicable), with or without reversibility testing (if indicated on spirometry). Measures respiratory impedance during normal tidal breathing.

DIAGNOSTIC_TEST

FENO

Fractional exhaled nitric oxide (if requested). Used to assess airway inflammation.

DIAGNOSTIC_TEST

Gas Transfer

Assesses lung diffusing capacity, performed using full pulmonary function testing equipment

DIAGNOSTIC_TEST

Static Lung Volumes

Body plethysmography (if applicable). Used to assess static lung volumes and, where applicable, specific resistance, performed using full lung function equipment

DIAGNOSTIC_TEST

Spirometry

Spirometry, with or without reversibility testing

Sponsors & Collaborators

  • Hampshire Hospitals NHS Foundation Trust

    collaborator OTHER
  • University of Southampton

    collaborator OTHER
  • TidalSense

    collaborator INDUSTRY
  • NIHR Southampton Respiratory Biomedical Research Centre

    collaborator UNKNOWN
  • Restech Srl

    collaborator INDUSTRY
  • University Hospital Southampton NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2027-08-31
Completion
2029-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07798596 on ClinicalTrials.gov